LoadingGRX
Saba Capital Management, L.P. reported Purchase in Gabelli Healthcare & WellnessRx Trust: 300 units of Common Stock, dated 2026-10-27. The full Form 4 contains 1 transaction entry.
CRSP
Kulkarni Samarth reported Grant or award in CRISPR Therapeutics AG: 57500 units of Stock Option (Right to Buy) (derivative), dated 2026-10-26. The full Form 4 contains 2 transaction entries.
CRSP
KASINGER JAMES R. reported Grant or award in CRISPR Therapeutics AG: 18000 units of Stock Option (Right to Buy) (derivative), dated 2026-10-26. The full Form 4 contains 2 transaction entries.
CRSP
Silver Andrew Jacob reported Grant or award in CRISPR Therapeutics AG: 18000 units of Stock Option (Right to Buy) (derivative), dated 2026-10-26. The full Form 4 contains 2 transaction entries.
DSM
Saba Capital Management, L.P. reported Purchase in BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.: 13695 units of Common Stock, dated 2026-10-27. The full Form 4 contains 1 transaction entry.
BPRE
KAMFAR RAMIN reported Purchase in Bluerock Private Real Estate Fund: 109019 units of Common Shares of Beneficial Interest, dated 2026-10-26. The full Form 4 contains 2 transaction entries.
FFBC
Massa Timothy A reported 1,300 shares of Common Stock in FIRST FINANCIAL BANCORP /OH/ as grants or awards dated 2026-10-27. The Form 4 was disclosed on Oct 28, 2026. These were stock awards, not open-market purchases.
FSLY
Compton Charles Lacey III reported Sale in Fastly, Inc.: 8941 units of Class A Common Stock, dated 2026-10-26. The full Form 4 contains 1 transaction entry.
SAIL
HAGAN JAMES MALCOLM reported Sale in SailPoint, Inc.: 4205 units of Common Stock, dated 2026-10-27. The full Form 4 contains 1 transaction entry.
ECF
Saba Capital Management, L.P. reported Purchase in ELLSWORTH GROWTH & INCOME FUND LTD: 400 units of Common Stock, dated 2026-10-27. The full Form 4 contains 1 transaction entry.
LYCA
Versant Ventures VII GP, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VII GP-GP, LLC; Versant Vantage II, L.P.; Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC reported Conversion in Lycia Therapeutics, Inc.: 5631425 units of Common Stock, dated 2026-10-26. The full Form 4 contains 4 transaction entries.
HXL
KEATING NEAL J. reported Purchase in HEXCEL CORP /DE/: 3000 units of Common Stock, dated 2026-10-26. The full Form 4 contains 1 transaction entry.
CRBG
NIPPON LIFE INSURANCE CO reported Purchase in Corebridge Financial, Inc.: 182826 units of Common Stock, dated 2026-10-26. The full Form 4 contains 1 transaction entry.
GF
Saba Capital Management, L.P. reported Purchase in NEW GERMANY FUND INC: 3648 units of Common Stock, dated 2026-10-27. The full Form 4 contains 1 transaction entry.
PDX
Saba Capital Management, L.P. reported Sale in PIMCO Dynamic Income Strategy Fund: 2855 units of Common Stock, dated 2026-10-27. The full Form 4 contains 1 transaction entry.
RLYB
Chung Wendy reported Exercise or conversion in Rallybio Corp: 2062 units of Common Stock, dated 2026-10-26. The full Form 4 contains 2 transaction entries.
RLYB
Lieber Jonathan I reported Grant or award in Rallybio Corp: 2500 units of Common Stock, dated 2026-10-26. The full Form 4 contains 2 transaction entries.
MSGR
DOLAN JAMES LAWRENCE reported Other (see filing) in MSG Rangers Corp.: 100 units of Common Stock, par value $0.01 per share, dated 2026-10-20. The full Form 4 contains 12 transaction entries.
MSGR
WEBER MARIANNE DOLAN reported Other (see filing) in MSG Rangers Corp.: 100 units of Common Stock, par value $0.01 per share, dated 2026-10-20. The full Form 4 contains 7 transaction entries.
MSGR
DOLAN QUENTIN F reported Other (see filing) in MSG Rangers Corp.: 220 units of Class A Common Stock, dated 2026-10-26. The full Form 4 contains 3 transaction entries.
MSGR
DOLAN-SWEENEY DEBORAH A reported Other (see filing) in MSG Rangers Corp.: 100 units of Common Stock, par value $0.01 per share, dated 2026-10-20. The full Form 4 contains 9 transaction entries.
MSGR
CHARLES F. DOLAN CHILDREN TRUST FBO JAMES L. DOLAN; CHARLES F. DOLAN CHILDREN TRUST FBO KATHLEEN M. DOLAN; CHARLES F. DOLAN CHILDREN TRUST FBO MARIANNE DOLAN WEBER; CHARLES F. DOLAN CHILDREN TRUST FBO DEBORAH DOLAN-SWEENEY reported Other (see filing) in MSG Rangers Corp.: 100 units of Common Stock, par value $0.01 per share, dated 2026-10-20. The full Form 4 contains 13 transaction entries.
MSGR
CHARLES F. DOLAN CHILDREN TRUST FBO THOMAS C. DOLAN reported Other (see filing) in MSG Rangers Corp.: 100 units of Common Stock, par value $0.01 per share, dated 2026-10-20. The full Form 4 contains 7 transaction entries.
MSGR
CHARLES F. DOLAN 2009 FAMILY TRUST FBO THOMAS C. DOLAN reported Other (see filing) in MSG Rangers Corp.: 100 units of Common Stock, par value $0.01 per share, dated 2026-10-20. The full Form 4 contains 7 transaction entries.
